![]() Intersect ENT Intersect ENT (also known as Medtronic Ear, Nose & Throat) is an ear, nose, and throat medical technology company. | ![]() Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. | ||
Founding Date | Founding Date 2003 | Founding Date 1988 | Founding Date 2000 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 4337% increase | Employees 15,1068% increase | Employees 2048% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 102.2 b | Valuation ($) 118.1 m |
Financial | |||
Revenue (est.) | Revenue (est.) $106.7m (FY, 2021) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $30m (FY, 2021) | Cost of goods N/A | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $76.7m (FY, 2021) | Gross profit N/A | Gross profit $71m (FY, 2024) |
Net income | Net income ($159.6m) (FY, 2021) | Net income $4.5b (FY, 2025) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | |||
Patents (US) | Patents (US) 30 (FY, 2016) | Patents (US) 31 (FY, 2020) | Patents (US) 43 (Jun, 2017) |
Products | Products 2 (FY, 2016) | Products 11 (FY, 2022) | Products N/A |
Trademarks | Trademarks 29 (FY, 2016) | Trademarks 20 (FY, 2022) | Trademarks N/A |
Trademarks (US) | Trademarks (US) 4 (FY, 2016) | Trademarks (US) N/A | Trademarks (US) 3 (Jun, 2017) |
Funding | |||
Total funding raised | Total funding raised $ 102.9m | Total funding raised $ 53.9m | Total funding raised $ 120.5m |

Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View company
OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company